Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System

Journal of Addiction Medicine

Volumn 11, Issue 1, 2017, Pages 3-9

  Bahorik, Amber L ^a   Satre, Derek D ^a,b   Kline Simon, Andrea H ^b   Weisner, Constance M ^a,b   Campbell, Cynthia I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

behavioral health care; disease burden; integrated health care; medical comorbidity; substance use disorder

Indexed keywords

ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; COCAINE; OPIATE; PSYCHEDELIC AGENT;

ADULT; ALCOHOLISM; AMPHETAMINE DEPENDENCE; ARTICLE; CANNABIS ADDICTION; CHARLSON COMORBIDITY INDEX; COCAINE DEPENDENCE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSESSMENT; DISEASE BURDEN; DRUG DEPENDENCE; ELECTRONIC HEALTH RECORD; FEMALE; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OPIATE ADDICTION; OUTCOME ASSESSMENT; PREVALENCE; PRIVATE HEALTH INSURANCE; ALCOHOL-RELATED DISORDERS; CALIFORNIA; COMORBIDITY; ECONOMICS; MARIJUANA ABUSE; MIDDLE AGED; MORTALITY; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA;

ADULT; ALCOHOL-RELATED DISORDERS; CALIFORNIA; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; MORTALITY; OPIOID-RELATED DISORDERS;

EID: 85015374714     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000260     Document Type: Article

References (40)

1. Aldington S, Harwood B, Cox B, et al. Cannabis use and risk of lung cancer: acase-control study. Eur Respir J 2008;31:280-286.
2. Barry CL, Huskamp HA. Moving beyond parity: mental health and addictioncare under the ACA. N Engl J Med 2011;356:973-975.
3. Berthiller J, Straif K, Boniol M, et al. Cannabis smoking and risk of lungcancer in men: a pooled analysis of three studies in Maghreb. J ThoracOncol 2008;3:1398-13403.
4. Birnbaum H, White A, Schiller M, et al. Societal costs of prescription opioidabuse, dependence, and misuse in the United States. Pain Med 2011;12:657-667.
5. Boyd C, Leff B, Weiss C, et al. Clarifying Multi-morbidity Patterns toImprove Targeting and Delivery of Clinical Services for Medicaid Populations. Center for Health Care Strategies; 2010.
6. Brady KT, McCauley J, Back SE. Prescription opioid misuse, abuse, andtreatment in the United States: an update. Am J Psychiatry Adv 2016;173:18-26.
7. Centers for Disease Control. Morbidity and MortalityWeekly Report. Deathsfrom Drug Poisoning and Drug Poisoning Involving Opioid Analgesics-United States, 1999-2013-United States, 1999-2013. Atlanta, GA:Centers for Disease Control and Prevention; 2015.
8. Charlson M, Charlson R, Peterson J, et al. The Charlson Comorbidity Index isadapted to predict costs of chronic disease in primary care patients. J ClinEpidemiol 2008;61:1234-1240.
9. Cherpitel CJ, Yu Y. Drug use and problem drinking associated with primarycare and emergency room utilization in the US general population: datafrom the 2005 national alcohol survey. Drug Alcohol Depend 2008;97:226-230.
10. Clark R, Samnaliev M, McGovern M. Impact of substance use disorders onmedical expenditures for Medicaid beneficiaries with behavioral healthdisorders. Psychiat Serv 2009;60:35-42.
11. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and theircontribution to the global burden of disease. Lancet 2012;379:55-70.
12. Degenhardt L, Whiteford H, Ferrari H, et al. Global burden of diseaseattributable to illicit drug use and dependence: findings from the GlobalBurden of Disease Study 2010. Lancet 2013;382:1564-1570.
13. Dickinson W, Miller B. Comprehensiveness and continuity of care and theinseparability of mental and behavioral health from the patient-centeredmedical home. Fam Syst Health 2010;28:348-355.
14. Edlund M, Martin B, Fan M, et al. Risks for opioid abuse and dependenceamong recipients of opioid therapy: results from the TROUP study. DrugAlcohol Depend 2010;112:90-98.
15. Edlund M, Steffick D, Hudson T, et al. Risk factors for clinically recognizedopioid abuse and dependence among veterans using opioids for chronicnon-cancer pain. Pain 2007;129:355-362.
16. Friedmann PD, Zhang Z, Hendrickson J, et al. Effect of primary medical careon addiction and medical severity in substance abuse treatment programs. J Gen Int Med 2003;18:1-8.
17. Future of Family Medicine Project Leadership Committee. The future offamily medicine: a collaborative project of the family medicine community. Ann Fam Med 2004;2(suppl 1):S3-S32.
18. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383-1391.
19. Hocherg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-803.
20. Institute of Medicine. Improving the Quality of Health Care for Mental andSubstance Use Conditions: Quality Chasm Series. Washington, DC:National Academies Press; 2006.
21. Kronik R, Bella M, Gilmer T. The Faces of Medicaid III: Refining the Portraitof People With Chronic Conditions. Center for Health Care Strategies;2009 October.
22. Mann K, Schafer D, Langle G, et al. The long-term course of alcoholism, 5, 10and 16 years after treatment. Addiction 2005;100:797-805.
23. Mark T, Levit K, Yee T, et al. Spending on mental and substance use disordersprojected to grow more slowly than all health spending through 2010. Health Affair 2014;8:1407-1415.
24. Mertens J, Lu Y, Parthasarathy S, et al. Medical and psychiatric conditions ofalcohol and drug treatment patients in an HMO: comparison with matchedcontrols. Arch Intern Med 2003;163:2511-2517.
25. Nordstrom T. Per capita alcohol consumption and all-cause mortality inCanada, 1950-1998. Addiction 2004;99:1274-1278.
26. Parthasarthy S, Mertens J, Moore C, et al. Utilization and cost impact ofintegrating substance abuse treatment and primary care. Med Care 2003;41:357-367.
27. R Development Core Team. R: A Language and Environment for StatisticalComputing. R Foundation for Statistical Computing (Version 2. 14. 2). [Computer Software]. Vienna, Austria: R Foundation for Statistical Computing;2015.
28. Ray GT, Collin F, Lieu T, et al. The cost of health conditions in a healthmaintenance organization. Med Care Res Rev 2000;57:92-109.
29. Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury andeconomic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009;373:2223-2233.
30. Rice J, White A, Birnbaum H, et al. A model to identify patients at risk forprescription opioid abuse, dependence and misuse. Pain Med 2012;13:1162-1173.
31. Schuckit M. Alcohol-use disorders. Lancet 2009;373:493-501.
32. Sorace J, Wong H, Worrall C, et al. The complexity of disease combinations inMedicare population. Popul Health Manag 2011;14:161-166.
33. Substance Abuse and Mental Health Services Administration, Center for BehavioralHealth Statistics and Quality. The NSDUH Report: Substance Use andMental Health Estimates from the 2013. National Survey on Drug Use andHealth: Overview of Findings. Rockville, MD; 2014, Septembe. r 4
34. Substance Abuse and Mental Health Services Administration, Center forBehavioral Health Statistics and Quality. Results from the 2014 NationalSurvey on Drug Use and Health: Summary of National Findings (HHSPublication No. SMA 15-4927, NSDUH Series H-50). Substance Abuseand Mental Health Services Administration, Center for Behavioral HealthStatistics and Quality; 2015. Available at: http://www. samhsa. gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014. pdf. AccessAugust 29, 2016.
35. Tetault J, Crothers K, Moore B, et al. Effects of marijuana smoking onpulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007;167:221-228.
36. Volkow N, Frieden T, Hyde P, et al. Medication-assisted therapies: tacklingthe opioid-overdose epidemic. N Engl J Med 2014;370:2063-2066.
37. Weisner C, Mertens J, Parthasarathy S, et al. Integrating primary medical carewith addiction treatment: a randomized controlled trial. JAMA 2001;286:1715-1723.
38. White A, Birnbaum H, Schiller M, et al. Analytic models to identify patientsat risk for prescription opioid abuse. Am J Manag C 2009;15:897-906.
39. Whiteford H, Degenhardt L, Rehm J, et al. Global burden of diseaseattributable to mental and substance use disorders: findings from theGlobal Burden of Disease Study 2010. Lancet 2013;382:1575-1586.
40. Young JQ, Kline-Simon AH, Mordecai DJ, et al. Prevalence of behavioralhealth disorders and associated chronic disease burden in a commerciallyinsured health system: findings of a case-control study. Gen Hosp Psychiatr 2015;37:101-108.